Dr. Mark R. Lodico, MD
Pain Medicine (Pain Medicine (Anesthesiology) Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Stony Brook, School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 286
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: State University of New York at Stony Brook, School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pain Medicine (Anesthesiology) Physician primary
PA license MD047135L · WV license 27284 -
Specialist
PA license MD047135L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Advanced PAin Medicine PC (15 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 286
- Services billed
- 2,082
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Injection, midazolam hydrochloride, per 1 mg | 316 | 55 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 312 | 66 |
| Testing for presence of drug, by chemistry analyzers | 224 | 204 |
| Established patient office or other outpatient visit, 30-39 minutes | 184 | 110 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 157 | 150 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 98 | 80 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | 43 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 49 | 35 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 46 | 33 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 43 | 40 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Morphine Sulfate Er (morphine sulfate) Other prescribers in Wexford, PA | 658 |
| Xtampza Er (oxycodone myristate) Other prescribers in Wexford, PA | 469 |
| Pregabalin Other prescribers in Wexford, PA | 432 |
| Gabapentin Other prescribers in Wexford, PA | 344 |
| Fentanyl Other prescribers in Wexford, PA | 277 |
| Celecoxib Other prescribers in Wexford, PA | 156 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Wexford, PA | 155 |
| Buprenorphine Other prescribers in Wexford, PA | 137 |
| Oxycontin (oxycodone hcl) Other prescribers in Wexford, PA | 121 |
| Tramadol Hcl Er (tramadol hcl) Other prescribers in Wexford, PA | 79 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 7 payments worth $133 in total to this clinician.
| Collegium Pharmaceutical, Inc. | $96.26 |
|---|---|
| Tersera Therapeutics LLC | $23.09 |
| Spr Therapeutics, Inc | $13.35 |
| Food and Beverage | $133 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.